初诊高血糖患者胰岛素强化治疗临床观察

目的：探讨短期胰岛素强化治疗对初诊2型糖尿病患者近期及远期的临床疗效。方法选择我院56例初诊2型糖尿病患者，按年龄分为1组、2组，每组再按体重分为肥胖、非肥胖组，经胰岛素强化治疗1个月~3个月后，每3个月、6个月、1年、3年进行相关指数的监测并进行比较。结果经胰岛素强化治疗后3个月、6个月、1年、3年监测胰岛素抵抗指数（HOMIR）、C肽、甘油三酯（TG）、糖化血红蛋白（HbA1c）与治疗前比较均有显著改善，差异有统计学意义（P〈0.05）。结论对初诊2型糖尿病患者采用短期、早期胰岛素强化治疗，近、远期效果均较满意，值得临床推广应用。

Observation of the first diagnosis hyperglycemia in patients with insulin intensive therapy

Objective To evaluate the short-term insulin intensive treatment on the first diagnosis in patients with type 2 diabetes,high blood sugar in the near future and long-term clinical curative effect. Methods Select 56 cases first diagnosis in patients with type 2 diabetes,high blood sugar intoⅠgroups according to age, Ⅱgroup,each group then weight obesity,obesity,insulin improved 1-3 months after treatment,every 3 months,6 months,1 year,3 years of related index of monitoring and comparison. Results After insulin intensive therapy for 3 months,6 months,1 year,3 years monitoring and insulin resistance index（HOMIR）,C peptide,triglyceride（TG）and glycated hemoglobin（HbA1c）were significantly improved compared before treatment difference was statistically significant （P〈0.05）.Conclusion To the first diagnosis in patients with type 2 diabetes,high blood sugar is short-term,early insulin intensive therapy,immediate and long-term effects are all very satisfied,clinical use of worthy of popularizing.